Coronavirus Latest News

Coronavirus: China-made ‘ReCov’ vaccine may be better than Pfizer-BioNTech’s, New Zealand doctor says; Sydney faces ‘scariest period’ of pandemic

A group of young New Zealanders have become the first humans to trial a new second-generation Covid-19 vaccine from China’s Jiangsu Rec-Biotechnology.About 25 young people started being jabbed with the ReCov vaccine this week as a part of a clinical study run in partnership with New Zealand Clinical Research, which has centres in Auckland and Christchurch.The trial will see 100 people vaccinated with ReCov by September, with a larger trial involving thousands of participants likely to be…

Read the original article at South China Morning Post

Related Articles

Back to top button